BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
PRINCIPAL INVESTORS: Barclays Global Investors
Barclays Personal Investment Management
Cavendish Asset Management
Comdirect
Fidelity Investments
Gartmore Investment Management
Insight Investment Management
M&G Investment Management
SG Asset Management
BUSINESS STRATEGY: Research, develop and manufacture diagnostic kits and instrumentation for
the rapid detection of microorganisms and provide laboratory testing
services
AGREEMENTS: Name Products Content of Agreement Date
U.K.
Adenylate Kinase Assay technology license 1/98
Government's
Defense
Evaluation and
Research Agency
Technology
agreement
RESEARCH & DEVELOPMENT: Rapid microbiology methods for enumeration, identification and toxicity
measurements
PRODUCTS ON MARKET: Pharmaceutical, personal care and beverage test kits
Advance, Advance coupe and CellScan Innovate luminometers
Centre for Innovative Biology and
Environmental Technology
Chelammotil Building, National Highway 47, Ambattukavu
Aluva-6, Kerala, Kochi 683106, India
Phone: +91 484-2631135; Fax: +91 484-2682557
Web: www.cibet.org; E-mail: info@cibet.org
KEY PERSONNEL: P. Sunil Kumar; CEO
Sabu Abdulhameed, Ph.D.; President
G. Nagendra Prabhu, Ph.D.; Exec. VP and Director, R&D
Jayachandran K., Ph.D.; Exec. VP
Rajeev K. Sukumaran, Ph.D.; Sr. Scientist
Swapna TS, Ph.D.; Sr. Scientist
EMPLOYEES: 32 employees, 8 Ph.D.s
HISTORY: Founded in September 2005
Began biotech R&D in October 2005
STOCK-FINANCIAL HISTORY: Nonprofit agency
BUSINESS STRATEGY: Transfer scientific know-how in to viable eco-friendly technologies
Copyright ©2006 AHC Media ® 111